+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

Cancer Immunotherapy Market Report 2024-2034 - Product Thumbnail Image

Cancer Immunotherapy Market Report 2024-2034

  • Report
  • June 2024
  • 286 Pages
  • Global
From
Antibody Drug Conjugates Market Report 2025-2035 - Product Thumbnail Image

Antibody Drug Conjugates Market Report 2025-2035

  • Report
  • December 2024
  • 342 Pages
  • Global
From
From
STAT3 Inhibitors Market Opportunity & Clinical Trials Insight 2028 - Product Thumbnail Image

STAT3 Inhibitors Market Opportunity & Clinical Trials Insight 2028

  • Report
  • February 2025
  • 100 Pages
  • Global
From
From
From
From
From
From
From
Oncology Pharmaceuticals Market - Product Thumbnail Image

Oncology Pharmaceuticals Market

  • Report
  • October 2024
  • 181 Pages
  • Global
From
Antibody-Drug Conjugates: Technologies and Global Markets - Product Thumbnail Image

Antibody-Drug Conjugates: Technologies and Global Markets

  • Report
  • September 2024
  • 89 Pages
  • Global
From
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more